BXP — Beximco Pharmaceuticals Share News
0.000.00%
Last trade - 00:00
- £162.83m
- £237.24m
- BDT39.27bn
- 93
- 98
- 70
- 99
REG - Beximco Pharmaceut - Beximco announces Commercial Agreement with Mylan
AnnouncementREG - Beximco Pharmaceut - Half Year Results 2019-20
AnnouncementREG - Beximco Pharmaceut - Payment of Cash Dividend
AnnouncementREG - Beximco Pharmaceut - AGM Statement
AnnouncementREG - Beximco Pharmaceut - AGM Notification
AnnouncementREG - Beximco Pharmaceut - Results for First Quarter Ended 30 September 2019
AnnouncementREG - Beximco Pharmaceut - Results for the 12 month period ended 30 June 2019
AnnouncementREG - Beximco Pharmaceut - Notification of Preliminary Results and AGM
AnnouncementREG - Beximco Pharmaceut - Update on Dividend and Tax legislation changes
AnnouncementREG - Beximco Pharmaceut - Beximco launches fifth product in the US market
AnnouncementREG - Beximco Pharmaceut - Dividend and Tax changes for Bangladesh companies
AnnouncementREG - Beximco Pharmaceut - 3rd Quarter Results
AnnouncementREG - Beximco Pharmaceut - Beximco receives FDA approval for Cyproheptadine
AnnouncementREG - Beximco Pharmaceut - Beximco Pharma to Acquire Eight ANDAs from Sandoz
AnnouncementREG - Beximco Pharmaceut - Appointment of Broker
AnnouncementREG - Beximco Pharmaceut - Half Year Results 2018-19
AnnouncementREG - Beximco Pharmaceut - Payment of Cash Dividend
AnnouncementREG - Beximco Pharmaceut - EGM Statement
AnnouncementREG - Beximco Pharmaceut - AGM Statement
Announcement